SE446450B - Amidderivat av 5-pyrimidin-karbonsyror for anvendning vid psykiska besver, samt sett for deras framstellning - Google Patents
Amidderivat av 5-pyrimidin-karbonsyror for anvendning vid psykiska besver, samt sett for deras framstellningInfo
- Publication number
- SE446450B SE446450B SE7901493A SE7901493A SE446450B SE 446450 B SE446450 B SE 446450B SE 7901493 A SE7901493 A SE 7901493A SE 7901493 A SE7901493 A SE 7901493A SE 446450 B SE446450 B SE 446450B
- Authority
- SE
- Sweden
- Prior art keywords
- group
- och3
- symbols
- formula
- och
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/30—Halogen atoms or nitro radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/34—One oxygen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/34—One oxygen atom
- C07D239/36—One oxygen atom as doubly bound oxygen atom or as unsubstituted hydroxy radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/38—One sulfur atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Anesthesiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR7804921A FR2417506A1 (fr) | 1978-02-21 | 1978-02-21 | Nouveaux amides derives d'acides carboxyliques-5 pyrimidiniques utiles notamment dans le traitement des troubles du psychisme |
| FR7902286A FR2457286A2 (fr) | 1979-01-30 | 1979-01-30 | Nouveaux amides derives d'acides carboxyliques-5 pyrimidiniques, leur preparation et leur application en therapeutique |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SE7901493L SE7901493L (sv) | 1979-08-22 |
| SE446450B true SE446450B (sv) | 1986-09-15 |
Family
ID=26220449
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE7901493A SE446450B (sv) | 1978-02-21 | 1979-02-20 | Amidderivat av 5-pyrimidin-karbonsyror for anvendning vid psykiska besver, samt sett for deras framstellning |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US4250178A (de) |
| JP (1) | JPS54130585A (de) |
| AU (1) | AU526298B2 (de) |
| CA (1) | CA1096868A (de) |
| CH (1) | CH639078A5 (de) |
| DE (1) | DE2906461A1 (de) |
| ES (1) | ES477852A1 (de) |
| GB (1) | GB2014984B (de) |
| GR (1) | GR66581B (de) |
| IT (1) | IT1113438B (de) |
| LU (1) | LU80937A1 (de) |
| NL (1) | NL7901333A (de) |
| SE (1) | SE446450B (de) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3368618D1 (en) * | 1982-11-04 | 1987-02-05 | Ici Plc | Process for the extraction of metal values and novel metal extractants |
| US4743605A (en) * | 1987-02-24 | 1988-05-10 | Warner-Lambert Company | Saturated fatty acid amides as inhibitors of acyl-coa:cholesterol acyltransferase |
| DE4425143A1 (de) * | 1994-07-15 | 1996-01-18 | Basf Ag | Substituierte Pyrimidinverbindungen und deren Verwendung |
| US5811428A (en) * | 1995-12-18 | 1998-09-22 | Signal Pharmaceuticals, Inc. | Pyrimidine carboxamides and related compounds and methods for treating inflammatory conditions |
| JPH11512399A (ja) * | 1995-09-01 | 1999-10-26 | シグナル ファーマシューティカルズ，インコーポレイテッド | ピリミジンカルボキサミドおよび関連化合物ならびに炎症状態を処置するための方法 |
| ES2235368T3 (es) * | 1997-10-27 | 2005-07-01 | Sumitomo Pharmaceuticals Company, Limited | Derivados de amida para tratar alteraciones neurodegenerativas de la retina. |
| US7504396B2 (en) * | 2003-06-24 | 2009-03-17 | Amgen Inc. | Substituted heterocyclic compounds and methods of use |
| TW200827346A (en) * | 2006-11-03 | 2008-07-01 | Astrazeneca Ab | Chemical compounds |
| TW200836719A (en) * | 2007-02-12 | 2008-09-16 | Astrazeneca Ab | Chemical compounds |
| AU2009211215B2 (en) * | 2008-02-04 | 2011-11-03 | Astrazeneca Ab | Novel crystalline forms of 4- [4- (2-adamantylcarbam0yl) -5-tert-butyl-pyrazol-1-yl] benzoic acid |
| AU2009239794A1 (en) * | 2008-04-22 | 2009-10-29 | Astrazeneca Ab | Substituted pyrimidin-5-carboxamides 281 |
| AU2015315177A1 (en) * | 2014-09-10 | 2017-03-16 | Epizyme, Inc. | Substituted pyrrolidine carboxamide compounds |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2789979A (en) * | 1954-09-22 | 1957-04-23 | Searle & Co | Basically substituted nu-alkyl-2-amino-4-hydroxy-5-pyrimidine carboxamides and salts thereof |
-
1979
- 1979-02-09 GR GR58323A patent/GR66581B/el unknown
- 1979-02-12 US US06/011,752 patent/US4250178A/en not_active Expired - Lifetime
- 1979-02-15 IT IT20206/79A patent/IT1113438B/it active
- 1979-02-19 CA CA321,796A patent/CA1096868A/en not_active Expired
- 1979-02-19 LU LU80937A patent/LU80937A1/xx unknown
- 1979-02-19 CH CH159879A patent/CH639078A5/fr not_active IP Right Cessation
- 1979-02-19 ES ES477852A patent/ES477852A1/es not_active Expired
- 1979-02-20 NL NL7901333A patent/NL7901333A/xx not_active Application Discontinuation
- 1979-02-20 GB GB7905890A patent/GB2014984B/en not_active Expired
- 1979-02-20 AU AU44392/79A patent/AU526298B2/en not_active Ceased
- 1979-02-20 DE DE19792906461 patent/DE2906461A1/de not_active Withdrawn
- 1979-02-20 SE SE7901493A patent/SE446450B/sv not_active IP Right Cessation
- 1979-02-20 JP JP1896279A patent/JPS54130585A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| DE2906461A1 (de) | 1979-08-23 |
| GB2014984B (en) | 1982-06-09 |
| NL7901333A (nl) | 1979-08-23 |
| AU4439279A (en) | 1979-07-19 |
| GB2014984A (en) | 1979-09-05 |
| US4250178A (en) | 1981-02-10 |
| JPS54130585A (en) | 1979-10-09 |
| SE7901493L (sv) | 1979-08-22 |
| LU80937A1 (fr) | 1979-10-29 |
| ES477852A1 (es) | 1979-08-01 |
| CA1096868A (en) | 1981-03-03 |
| GR66581B (de) | 1981-03-27 |
| IT1113438B (it) | 1986-01-20 |
| IT7920206A0 (it) | 1979-02-15 |
| AU526298B2 (en) | 1983-01-06 |
| CH639078A5 (fr) | 1983-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69516847T2 (de) | Chlorpyrimidine als zwischenprodukte | |
| DE3248160C2 (de) | 2-[4-[(4,4-Dialkyl-2,6-piperidindion-1-yl)-butyl]-1-piperazinyl]pyrimidine, Verfahren zu ihrer Herstellung und pharmazeutische Mittel, die diese Verbindungen enthalten | |
| DE60010234T2 (de) | 2-amino-6-anilino-purine und deren verwendung als arzneimittel | |
| DE69013607T2 (de) | Pyrazol-Derivate, Verfahren zu deren Herstellung und Anwendung. | |
| DE69713402T2 (de) | Liganden des neuropeptids y | |
| DE60311272T2 (de) | Neue purin- oder pyrrolol(2,3-d)pyrimidin-2-carbonsäurenitrile zur behandlung von mit cysteinproteaseaktivität assoziierten krankheiten | |
| DE69304883T2 (de) | Xanthin Derivate | |
| SE446450B (sv) | Amidderivat av 5-pyrimidin-karbonsyror for anvendning vid psykiska besver, samt sett for deras framstellning | |
| MXPA06009132A (es) | Inhibidores de integrasa de vih. | |
| JP2002537300A5 (de) | ||
| DE69130869T2 (de) | Xanthinderivate | |
| US9481649B2 (en) | Synthesis of a neurostimulative piperazine | |
| US6964960B2 (en) | Indoloquinazolinones | |
| US7176222B2 (en) | Syntheses of ureas | |
| DE69226590T2 (de) | Verfahren zur Herstellung von substituierten N-Aryl-1,2,4-Triazolopyrimidin-2-Sulfonamiden | |
| JP2018522862A (ja) | キサンチンをベースとする化合物の調製方法 | |
| DE69122427T2 (de) | Imidazonaphthyridinderivate | |
| WO2003039439A2 (de) | Deuterierte pyrazolopyrimidinone sowie diese verbindungen enthaltende arzneimittel | |
| JPH05117273A (ja) | 医薬化合物 | |
| EP0976742A1 (de) | Eine Synthese von Furansulfonamid-Derivaten zur Verwendung in der Herstellung von IL-1 Inhibitoren | |
| EP0121490B1 (de) | Substituierte 6-Aryl-1,2,4-triazolo[4,3-b]pyridazine, ihre Herstellung und Verwendung | |
| SE443560B (sv) | Analogiforfarande for framstellning av 1-amino-legre alkyl-3,4-difenyl-1h-pyrazoler | |
| JPH0269476A (ja) | ピリミジン誘導体の製法 | |
| US6184382B1 (en) | Process for preparing N6-substituted adenosine derivatives | |
| DK152501B (da) | Fremgangsmaade til fremstilling af pyrrolooe1,2-aaapyrimidiner eller salte deraf |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NUG | Patent has lapsed |
Ref document number: 7901493-2 Effective date: 19870915 Format of ref document f/p: F |